Trials / Completed
CompletedNCT06452082
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl
Retrospective Observational Study on the Risk Developing Long-COVID Syndrome After Acute COVID-19 Disease and in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl in Outpatients of Endocr Dept
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- IRCCS San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this observational retrospective study is to evaluate the effect of supplementation with cholecalciferol D3 in reducing the risk of: * occurence of Long COVID syndrome after acute COVID-19 illness * occurence of SARS-CoV-2 infection after anti-COVID-19 vaccination
Detailed description
Anamnestic, laboratory and therapeutic data will be collected during outpatient visits.
Conditions
Timeline
- Start date
- 2024-03-20
- Primary completion
- 2025-07-24
- Completion
- 2025-09-10
- First posted
- 2024-06-11
- Last updated
- 2026-04-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06452082. Inclusion in this directory is not an endorsement.